tiprankstipranks
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market

Fortress Biotech (FBIO) Income Statement

Compare
1,386 Followers

Fortress Biotech Income Statement

Last quarter (Q3 2024), Fortress Biotech's total revenue was $14.63M, a decrease of -57.90% from the same quarter last year. In Q3, Fortress Biotech's net income was $-12.87M. See Fortress Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 84.51M$ 75.74M$ 68.79M$ 45.60M$ 36.63M
Gross Profit
$ 57.85M$ 44.97M$ 36.71M$ 31.00M$ 26.10M
Operating Expenses
$ 200.19M$ 247.23M$ 215.71M$ 125.28M$ 136.92M
Depreciation and Amortization
$ 8.07M$ 9.35M$ 6.79M$ 5.33M$ 4.65M
EBITDA
$ -133.64M$ -190.47M$ -142.25M$ -87.82M$ -85.16M
Operating Income
$ -142.34M$ -202.26M$ -179.00M$ -94.27M$ -110.82M
Other Income/Expenses
$ -11.29M$ -9.90M$ 24.19M$ -8.58M$ 9.16M
Pretax Income
$ -153.63M$ -213.46M$ -164.35M$ -102.85M$ -101.66M
Net Income
$ -60.64M$ -213.91M$ -164.83M$ -102.98M$ -51.81M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.47$ -36.10$ -30.26$ -21.45$ -14.20
Diluted EPS
$ -8.47$ -36.10$ -30.26$ -21.45$ -14.20
Weighted Average Shares Outstanding
8.11M 5.92M 5.45M 4.80M 3.65M
Weighted Average Shares Outstanding (Diluted)
8.11M 5.92M 5.45M 4.80M 3.65M
Currency in USD

Fortress Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis